Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug Targets

Current Cancer Drug Targets · Published 2026-06-16 · DOI 10.2174/0115680096479876260608105824

Authors (8)

Victor Tomacinschii, Andreea Casian, Maria Robu, Sanda Buruiana, Natalia Sporis, Cristina Dudnic, Adrian Bogdan Tigu, Ciprian Tomuleasa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Tomacinschii, V., Casian, A., Robu, M., et al. (2026). Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug Targets. Current Cancer Drug Targets. https://doi.org/10.2174/0115680096479876260608105824

Related articles

• Advances in Pharmacological Therapy for Recurrent High-Grade Meningiomas · Current Cancer Drug Targets · 2026 · Same journal
• Ectophosphatase Activity in Human Hepatocellular Carcinoma Huh7 Cells:Characterisation and Implications for the Tumour Microenvironment · Current Cancer Drug Targets · 2026 · Same journal
• Screening of Demethylation-related Biomarkers and Exploration ofRegulatory Mechanisms in Esophageal Cancer Patients Based on MachineLearning and Mendelian Randomization · Current Cancer Drug Targets · 2026 · Same journal
• A Novel Oncogene and Therapeutic Target, Germ Cell-Specific Gene 2 (GSG2), Plays Complex Roles in Promoting Malignant Progression of Glioma · Current Cancer Drug Targets · 2026 · Same journal
• Sustained Disease Control with Niraparib in a Pediatric Patient withRecurrent Atypical Teratoid/Rhabdoid Tumor: A Case Report · Current Cancer Drug Targets · 2026 · Same journal
• Single-Cell and Computational Epigenomics in HGSOC: A Roadmap to Overcoming Chemoresistance · Current Cancer Drug Targets · 2026 · Same journal
• LncRNA ABCA9-AS1 as a ceRNA Promotes Gastric Cancer Progression bySponging miR-497-5p to Regulate KIF23 Expression · Current Cancer Drug Targets · 2026 · Same journal
• FAM117B and ZDHHC21 as Shared Targets in Periodontitis and Oropharyngeal Cancer: Cephaeline and Sanguinarine as Potential Therapeutics · Current Cancer Drug Targets · 2026 · Same journal
• Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets · Current Cancer Drug Targets · 2026 · Same journal
• Overcoming Immune Resistance in Bladder Cancer: From ExhaustedT-Cells and Microbiome Crosstalk to Next-Generation CombinationTherapies · Current Cancer Drug Targets · 2026 · Same journal